//16 Mar 2011
With the acquisition of King Pharmaceuticals by Pfizer, Inc. announced on February 28, Pfizer Animal Health will begin integrating Alpharma, LLC into its existing business.
Alpharma was a wholly owned subsidiary of King Pharmaceuticals and became part of Pfizer Animal Health with Pfizer’s acquisition of King.
Pfizer now adds Alpharma brands such as BOVATEC® (lasalocid), AUREOMYCIN® (chlortectracycline), DECCOX® (decoquinate) and BMD® (bacitracin methylene disalicylate) to its offerings.
These products complement the Pfizer portfolio that includes DRAXXIN® (tulathromycin), EXCEDE® (ceftiofur crystalline free acid), Bovi-Shield ® GOLD, FACTREL® (gonadorelin hydrochloride), the line of SYNOVEX® implants, as well as RESPISURE®, FLUSURE®, and the full line of SUVAXYN® brands.
No comments:
Post a Comment